Commercial scale manufacturing can still be cost prohibitive from a likely reimbursement rate perspective and or may not be able to ramp up for various reasons such as supply chain issues which was mentioned as a concern back in the day. These issues appear to have had enough time to be worked out based on the Qs and ks. What remains to be seen is scalable ramp with Flaskworks. Best wishes.
Market Data 
Markets 
AI
